People · Operator
Named in public records as an officer, director or promoter · active 2019–2022 · Other, Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TILT Holdings Inc. | — | Other | Series C | $102.2M | $43.6M | 2019 |
| National Spine & Pain Centers Holdings, LLC | — | Other Health Care | Series B | $32.0M | $708.9M | 2019 |
| Enalare Therapeutics Inc. | — | Pharmaceuticals | Series A | $23.5M | $150.9M | 2022 |
Mark Coleman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Coleman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Chris Kelly | 1 | 9 |
| GARY SMITH | 1 | 8 |
| Sriram Venkataraman | 1 | 6 |
| Gino Santini | 1 | 5 |
| Thompson Dean | 1 | 3 |
| Michael Orr | 1 | 3 |
| BRIAN MARKISON | 1 | 3 |
| DAVID MCCABE | 1 | 3 |
| Derace Schaffer | 1 | 2 |
| Joel Milton | 1 | 2 |
| Jerome Rhodes | 1 | 2 |
| Adam Draizin | 1 | 2 |
| Joseph Pergolizzi | 1 | 2 |
| D'Angela Simms | 1 | 1 |
| George Odden | 1 | 1 |
| Brad Hoch | 1 | 1 |
| Tim Conder | 1 | 1 |
| D'Angela F. Simms | 1 | 1 |
| Brad F. Hoch | 1 | 1 |
| Tim F. Conder | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.